Return to homepagePandemic Pact

Coronavirus Immunoassay Core

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 4U54CA260581-02

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2025

  • Known Financial Commitments (USD)

    $372,984

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    JAMES Robinson

  • Research Location

    United States of America

  • Lead Research Institution

    TULANE UNIVERSITY OF LOUISIANA

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    N/A

Abstract

Immunology Core Summary The overall objective of the Immunoassay core is to provide high quality materials that will make feasible the studies proposed in projects 1 and 2, and especially to assure that studies are using reagents and pretested materials that will produce reliable and reproducible results. The core will provide purified recombinant viral proteins for use in both projects and provide binding and functional immunoassays for in depth analysis of antibody responses to SARS CoV-2 in different population groups over a period of follow-up. The core is made up of two labs, one at Tulane and one at WSU, which will function in close collaboration to achieve our aims